Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Minehunter
|
gptkbp:activeDuring |
gptkb:iron_sucrose
|
gptkbp:administrativeDivision |
administered over 2 to 5 minutes
may be given as a slow infusion |
gptkbp:clinicalTrials |
treatment of chronic kidney disease
recommended for use in patients with chronic kidney disease recommended for use in cancer patients with anemia recommended for use in hemodialysis patients studied in patients undergoing hemodialysis studied in patients with cancer-related anemia studied in patients with chronic kidney disease treatment of patients on dialysis treatment of patients with cancer |
gptkbp:contraindication |
allergic reactions
fever chills injection site reactions muscle cramps severe liver disease severe renal impairment anemia not due to iron deficiency known hypersensitivity to iron sucrose |
gptkbp:date |
2000-12-29
|
gptkbp:dosageForm |
injection solution
|
gptkbp:drugInterdiction |
iron is released slowly into the bloodstream
|
gptkbp:formulation |
contains iron in a stable form
contains sucrose as a stabilizer contains water for injection |
https://www.w3.org/2000/01/rdf-schema#label |
Venofer
|
gptkbp:interactsWith |
may interact with certain antibiotics
may interact with oral iron supplements may interact with other intravenous iron products |
gptkbp:issuedBy |
intravenous injection
|
gptkbp:mandates |
iron deficiency in patients with chronic kidney disease
iron deficiency in patients on hemodialysis iron deficiency in patients with cancer |
gptkbp:manufacturer |
gptkb:American_Regent,_Inc.
|
gptkbp:packaging |
vials
|
gptkbp:route |
intravenous
|
gptkbp:safety |
generally well tolerated
monitor for allergic reactions monitor for infusion-related reactions |
gptkbp:sideEffect |
dizziness
headache nausea vomiting hypotension |
gptkbp:storage |
store at room temperature
protect from light |
gptkbp:triggerType |
provides iron for erythropoiesis
increases hemoglobin levels |
gptkbp:usedFor |
iron deficiency anemia
|